Description: Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
Home Page: www.hanmipharm.com
14, Wiryeseong-daero
Seoul,
05545
South Korea
Phone:
82 2 410 9114
Officers
| Name | Title |
|---|---|
| Mr. Jong-Soo Woo Ph.D. | CEO, Pres & Exec. Director |
| Mr. Se-Chang Kwon | CEO, Pres & Exec. Director |
| Mr. Gwan-Sun Lee Ph.D. | Exec. Vice Chairman & Exec. of Global Strategy |
| Mr. Chang-Hee Han | Sr. VP Management Support Division |
| Mr. Lim Chong-Yoon | Pres of Bus. Devel. & Exec. Director |
| Mr. Moon-Kyee Ju | Sr. Managing Director |
| Maeng-Sub Kim | Head of Research Center and Managing Director |
| Mr. Jong-Ho Lim | CSR Exec. Director |
| Mr. Jong-Woo Park | Managing Director |
| Ms. Ju-Hyun Lim | Sr. Managing Director |
Exchange: KO
Country: KR
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.083 |
| Price-to-Sales TTM: | 2.6651 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2121 |